Salicin, an extract from white willow bark, inhibits angiogenesis by blocking the ROS-ERK pathways

Phytotherapy Research

Volumn 28, Issue 8, 2014, Pages 1246-1251

  Kong, Chang Seok ^a   Kim, Ka Hyun ^a   Choi, Jae Sun ^a   Kim, Ja Eun ^a   Park, Chan ^a   Jeong, Joo Won ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

angiogenesis; ERK; ROS; salicin; tumor progression

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; SALICIN; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BARK; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELL MIGRATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG SCREENING; DRUG STRUCTURE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CARCINOMA; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WHITE WILLOW; WILLOW;

MUS; SALIX ALBA;

ANGIOGENESIS; ERK; ROS; SALICIN; TUMOR PROGRESSION;

ANGIOGENESIS INHIBITORS; ANIMALS; AORTA; BENZYL ALCOHOLS; CELL LINE, TUMOR; GLUCOSIDES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED BALB C; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; PLANT BARK; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SALIX;

EID: 84905641320     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5126     Document Type: Article

References (38)

1. Bonaterra GA, Kelber O, Weiser D, Metz J, Kinscherf R,. 2010. In vitro anti-proliferative effects of the willow bark extract STW 33-I. Arzneimittelforschung 60 (6): 330-335.
2. Borthwick GM, Johnson AS, Partington M, Burn J, Wilson R, Arthur HM,. 2006. Therapeutic levels of aspirin and salicylate directly inhibit a model of angiogenesis through a Cox-independent mechanism. Faseb J 20 (12): 2009-2016.
3. Carmeliet P,. 2005. Angiogenesis in life, disease and medicine. Nature 438 (7070): 932-936.
4. Carmeliet P, Jain RK,. 2000. Angiogenesis in cancer and other diseases. Nature 407 (6801): 249-257.
5. Chung BH, Kim JD, Kim CK, et al,. 2008. Icariin stimulates angiogenesis by activating the MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways in human endothelial cells. Biochem Biophys Res Commun 376 (2): 404-408.
6. Dai J, Peng L, Fan K, et al,. 2009. Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells. Oncogene 28 (38): 3412-3422.
7. Ferrara N, Gerber HP, LeCouter J,. 2003. The biology of VEGF and its receptors. Nature Medicine 9 (6): 669-676.
8. Freischmidt A, Jurgenliemk G, Kraus B, et al,. 2012. Contribution of flavonoids and catechol to the reduction of ICAM-1 expression in endothelial cells by a standardised Willow bark extract. Phytomedicine 19 (3-4): 245-252.
9. Gupta SC, Kim JH, Prasad S, Aggarwal BB,. 2010. Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Reviews 29 (3): 405-434.
10. Hedner T, Everts B,. 1998. The early clinical history of salicylates in rheumatology and pain. Clinical Rheumatology 17 (1): 17-25.
11. Hostanska K, Jurgenliemk G, Abel G, Nahrstedt A, Saller R,. 2007. Willow bark extract (BNO1455) and its fractions suppress growth and induce apoptosis in human colon and lung cancer cells. Cancer Detection and Prevention 31 (2): 129-139.
12. Hu Y, Wang X, Zeng L, et al,. 2005. ERK phosphorylates p66shcA on Ser36 and subsequently regulates p27kip1 expression via the Akt-FOXO3a pathway: implication of p27kip1 in cell response to oxidative stress. Molecular Biology of the Cell 16 (8): 3705-3718.
13. Ishikado A, Sono Y, Matsumoto M, et al,. 2012. Willow bark extract increases antioxidant enzymes and reduces oxidative stress through activation of Nrf2 in vascular endothelial cells and Caenorhabditis elegans. Free Radical Biology & Medicine 65: 1506-1515.
14. Jiang BH, Liu LZ,. 2009. PI3K/PTEN signaling in angiogenesis and tumorigenesis. Advances in Cancer Research 102: 19-65.
15. Khaidakov M, Szwedo J, Mitra S, et al,. 2010. Antiangiogenic and antimitotic effects of aspirin in hypoxia-reoxygenation modulation of the LOX-1-NADPH oxidase axis as a potential mechanism. Journal of Cardiovascular Pharmacology 56 (6): 635-641.
16. Koch S, Tugues S, Li X, Gualandi L, Claesson-Welsh L,. 2011. Signal transduction by vascular endothelial growth factor receptors. The Biochemical Journal 437 (2): 169-183.
17. Luczak K, Balcerczyk A, Soszynski M, Bartosz G,. 2004. Low concentration of oxidant and nitric oxide donors stimulate proliferation of human endothelial cells in vitro. Cell Biology International 28 (6): 483-486.
18. Maxwell PH, Ratcliffe PJ,. 2002. Oxygen sensors and angiogenesis. Seminars in Cell & Developmental Biology 13 (1): 29-37.
19. Milkiewicz M, Mohammadzadeh F, Ispanovic E, Gee E, Haas TL,. 2007. Static strain stimulates expression of matrix metalloproteinase-2 and VEGF in microvascular endothelium via JNK- and ERK-dependent pathways. Journal of Cellular Biochemistry 100 (3): 750-761.
20. Nahrstedt A, Schmidt M, Jaggi R, Metz J, Khayyal MT,. 2007. Willow bark extract: the contribution of polyphenols to the overall effect. Wiener medizinische Wochenschrift (1946) 157 (13-14): 348-351.
21. Nordgren IK, Tavassoli A,. 2011. Targeting tumour angiogenesis with small molecule inhibitors of hypoxia inducible factor. Chemical Society Reviews 40 (8): 4307-4317.
22. Pages G, Pouyssegur J,. 2005. Transcriptional regulation of the vascular endothelial growth factor gene - a concert of activating factors. Cardiovascular Research 65 (3): 564-573.
23. Park HJ, Kim SR, Bae SK, et al,. 2009. Neuromedin B induces angiogenesis via activation of ERK and Akt in endothelial cells. Experimental Cell Research 315 (19): 3359-3369.
24. Rak J, Mitsuhashi Y, Sheehan C, et al,. 2000. Oncogenes and tumor angiogenesis: differential modes of vascular endothelial growth factor up-regulation in ras-transformed epithelial cells and fibroblasts. Cancer Research 60 (2): 490-498.
25. Schmid B, Kotter I, Heide L,. 2001. Pharmacokinetics of salicin after oral administration of a standardised willow bark extract. European Journal of Clinical Pharmacology 57 (5): 387-391.
26. Shono T, Ono M, Izumi H, et al,. 1996. Involvement of the transcription factor NF-kappaB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress. Molecular and Cellular Biology 16 (8): 4231-4239.
27. Srivastava P, Singh VK, Singh BD, Srivastava G, Misra BB, Tripathi V,. 2013. Screening and Identification of Salicin Compound from Desmodium gangeticum and its In vivo Anticancer Activity and Docking Studies with Cyclooxygenase (COX) Proteins from Mus musculus. J Proteomics Bioinform 6: 109-124.
28. Ushio-Fukai M, Nakamura Y,. 2008. Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Letters 266 (1): 37-52.
29. Vepa S, Scribner WM, Parinandi NL, English D, Garcia JG, Natarajan V,. 1999. Hydrogen peroxide stimulates tyrosine phosphorylation of focal adhesion kinase in vascular endothelial cells. The American Journal of Physiology 277 (1 Pt 1): L150-158.
30. Wang X, Liu JZ, Hu JX, et al,. 2011. ROS-activated p38 MAPK/ERK-Akt cascade plays a central role in palmitic acid-stimulated hepatocyte proliferation. Free Radical Biology & Medicine 51 (2): 539-551.
31. Wang YD, Hu Y, Zhang L, Sun CY,. 2008. Brain derived neurotrophic factor induces endothelial cells angiogenesis through AKT and ERK1/2 signal pathway. Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui-=-Journal of experimental hematology / Chinese Association of Pathophysiology 16 (1): 175-180.
32. Wang Z, Brecher P,. 1999. Salicylate inhibition of extracellular signal-regulated kinases and inducible nitric oxide synthase. Hypertension 34 (6): 1259-1264.
33. Wu HW, Li HF, Wu XY, Zhao J, Guo J,. 2008. Reactive oxygen species mediate ERK activation through different Raf-1-dependent signaling pathways following cerebral ischemia. Neuroscience Letters 432 (2): 83-87.
34. Yang JY, Zong CS, Xia W, et al,. 2008. ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation. Nature Cell Biology 10 (2): 138-148.
35. Yasuda M, Ohzeki Y, Shimizu S, et al,. 1999. Stimulation of in vitro angiogenesis by hydrogen peroxide and the relation with ETS-1 in endothelial cells. Life Sciences 64 (4): 249-258.
36. Yoon SO, Park SJ, Yoon SY, Yun CH, Chung AS,. 2002. Sustained production of H(2)O(2) activates pro-matrix metalloproteinase-2 through receptor tyrosine kinases/phosphatidylinositol 3-kinase/NF-kappa B pathway. The Journal of Biological Chemistry 277 (33): 30271-30282.
37. Zhang L, Yang N, Katsaros D, et al,. 2003. The oncogene phosphatidylinositol 3'-kinase catalytic subunit alpha promotes angiogenesis via vascular endothelial growth factor in ovarian carcinoma. Cancer Research 63 (14): 4225-4231.
38. Zhang X, Wang Z, Wang Z, et al,. 2013. Impact of acetylsalicylic acid on tumor angiogenesis and lymphangiogenesis through inhibition of VEGF signaling in a murine sarcoma model. Oncology Reports 29 (5): 1907-1913.